Elocon vs Fluticasone in Localized Psoriasis

Trial Profile

Elocon vs Fluticasone in Localized Psoriasis

Phase of Trial: Phase IV

Latest Information Update: 29 Sep 2017

At a glance

  • Drugs Mometasone (Primary) ; Fluticasone propionate
  • Indications Psoriasis
  • Focus Therapeutic Use
  • Acronyms P03197
  • Sponsors Merck Sharp & Dohme
  • Most Recent Events

    • 29 Sep 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top